Sign in
4

Changes in Ownership

ALX ONCOLOGY HOLDINGS INC Filed Acc 0001209191-23-039103

Options or other derivatives

  • Director acquired 20,200 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Lettmann Jason Director 2023-06-20 Grant or award · Stock option (right to buy) +20,200 20,200 D: show line 1 in the form
Loading xslF345X04/doc4.xml…